Clinical Trial Update: Renal Effect of Stribild or Other Tenofovir DF-containing Regimens Compared to Ritonavir-boosted Atazanavir Plus Abacavir/Lamivudine in Antiretroviral Treatment-naive HIV-1 Infected Adults [Phase 4]

View source ↗

Summary

Phase 4 trial comparing renal effects of Stribild and other tenofovir disoproxil fumarate regimens with ritonavir-boosted atazanavir plus abacavir/lamivudine in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Stribild (elvitegravir; cobicistat; emtricitabine; tenofovir disoproxil fumarate)
• ritonavir-boosted atazanavir + abacavir/lamivudine (atazanavir boosted with ritonavir; abacavir/lamivudine)

Snippet

Sponsor: Gilead Sciences | Conditions: HIV-1 Infection | Phase 4 | Status: COMPLETED | Results posted: 2018-01-03